Real-life antimicrobial therapy in hospitalized patients with COVID-19 (preliminary results and recommendations)

Real-life antimicrobial therapy in hospitalized patients with COVID-19 (preliminary results and recommendations)

Objective. Development of local clinical protocols for antibacterial therapy of COVID-19-associated bacterial pneumonia in the therapeutic department of the city clinical hospital based on an analysis of the treatment process in patients with COVID-19-associated pneumonia. Materials and Methods....

Full description

Bibliographic Details
Main Authors:	Mitrokhin S.D., Orlova O.E., Yankovskaya O.S., Gosteva I.V., Galitskiy A.A., Karpova I.V., Vedyashkina S.G., Shkoda A.S.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2022-06-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	covid-19 inflammatory response markers secondary viralbacterial pneumonia antimicrobial therapy
Online Access:	https://cmac-journal.ru/publication/2022/2/cmac-2022-t24-n2-p181/cmac-2022-t24-n2-p181.pdf

Similar Items

Features of Clinical and X-ray Patterns of Community-Acquired Pneumonia in Children in Various Age Groups
by: Semernik OE, et al.
Published: (2019-01-01)

Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)

Analysis of clinical and paraclinical findings in children with community-acquired pneumonia and comorbid chronic tonsillitis
by: O. Teslitskyi, et al.
Published: (2023-04-01)

CLINICAL EFFECTIVENESS OF AZITHROMYCIN IN THE TREATMENT OF PNEUMONIA IN CHILDREN
by: N.D. Soroka, et al.
Published: (2006-01-01)

Features of Drug Treatment of Acute Community-Acquired Pneumonia in Children with Autonomic Imbalance and Significant Astenic Syndrome
by: S.L. Nyankovsky, et al.
Published: (2012-04-01)

Antibacterial therapy of hospital infections caused by carbapenemase-producing strains of K. pneumoniae
by: E.G. Antonova, et al.
Published: (2022-06-01)

Oral third-generation cephalosporin cefpodoxime in the therapy of respiratory infections
by: Stetsiouk O.U., et al.
Published: (2023-09-01)

Changes in the expression of molecular markers of peripheral blood lymphocyte activation in patients with small (T1) choroidal melanoma after transpupillary thermotherapy
by: I.V. Tsukanova, et al.
Published: (2019-10-01)

Diagnosis and antibiotic therapy of nosocomial pneumonia in adults: from recommendations to real practice. A review
by: Svetlana А. Rachina, et al.
Published: (2023-12-01)

Predictors of community-acquired pneumonia in patients with acute decompensated heart failure: the results of the analysis of the hospital sample EPOHA-D-CHF
by: D.S. Polyakov, et al.
Published: (2018-04-01)

Comparison of expression of molecular markers of peripheral blood lymphocyte activation in patients with small uveal melanoma and healthy controls
by: S.I. Poliakova, et al.
Published: (2016-12-01)

The Relationship of Leukocyte and Neutrophil Count, C-Reactive Protein, and Erythrocyte Sedimentation Rate With the Severity of Childhood Pneumonia Without Conjugated Pneumococcal Vaccine Use
by: Mohammad Bagher Rahmati
Published: (2022-07-01)

Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study
by: Hilal Sipahioglu, et al.
Published: (2022-07-01)

Evaluation of the BioFire FilmArray Pneumonia Panel Plus to the Conventional Diagnostic Methods in Determining the Microbiological Etiology of Hospital-Acquired Pneumonia
by: Noha A. Kamel, et al.
Published: (2022-02-01)

Pulmonary Fibrosis Secondary to COVID-19 Pneumonia and its Relation with Inflammatory Markers
by: Rohit Mehan, et al.
Published: (2023-11-01)

Pulmonary Fibrosis Secondary to COVID-19 Pneumonia and its Relation with Inflammatory Markers
by: Rohit Mehan, et al.
Published: (2023-07-01)

Differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adults
by: Strelkova D.A., et al.
Published: (2023-09-01)

Scientific-Biographical Method in Psychological and Legal Research: from Retrospective and Multivariate Analysis to Methodological Tools for Quality Assessment
by: I.V. Afanasieva, et al.
Published: (2024-04-01)

Lower respiratory tract infections treatment recommendations: An overview
by: Elli Malakounidou, et al.
Published: (2023-07-01)

Judicial practice as a legal tool and source of environmental law: problems of uniformity
by: Sachkov A.N., et al.
Published: (2023-01-01)

Clinical significance of adipokine profile (leptin and adiponectin) in patients with gout
by: I.V. Orlova, et al.
Published: (2023-06-01)

GC-MS profiling of volatile metabolites produced by Klebsiella pneumoniae
by: Wojciech Filipiak, et al.
Published: (2022-10-01)

Oxidative and nitrosative stress — the leading mechanisms of chronic pancreatitis and chronic obstructive pulmonary disease interaction and inducers of their progression
by: O.S. Khukhlina, et al.
Published: (2023-12-01)

In vitro activity of cefpodoxime against Russian clinical isolates of Haemophilus influenzae, Streptococcus pneumoniae and Streptococcus pyogenes
by: Kozlov R.S., et al.
Published: (2023-12-01)

PREVALENCE OF PNEUMOCOCCAL PNEUMONIAE AND OTITIDES IN INFANTS (PROVISIONAL DATA)
by: S.M. Kharit, et al.
Published: (2011-01-01)

Fecal aminoacid profile in infants depending on their age and sex characteristics, type of feedingand allergic anamnesis
by: A.A. Glazev, et al.
Published: (2023-04-01)

Role of CRP in COVID-19 pneumonia: A single-center experience of 1000 cases in a tertiary care setting in India
by: Shital Patil, et al.
Published: (2022-01-01)

Elevated lactate dehydrogenase predicts pneumonia in spontaneous intracerebral hemorrhage
by: Yangchun Xiao, et al.
Published: (2024-02-01)

Prevalence and serotypes of Streptococcus pneumoniae among under five children attending Toro general hospital, Bauchi State, Nigeria
by: Murna Ali, et al.
Published: (2023-05-01)

“Serial ferritin titer” monitoring in COVID-19 pneumonia: valuable inflammatory marker in assessment of severity and predicting early lung fibrosis — prospective, multicentric, observational, and interventional study in tertiary care setting in India
by: Shital Patil, et al.
Published: (2022-10-01)

A review on importance of biochemical markers in coronavirus disease (COVID-19)
by: Lagisetty L, et al.
Published: (2020-12-01)

PREVENTION OF NOSOCOMIAL PNEUMONIAS IN A SURGICAL INTENSIVE CARE UNIT
by: O. A. Orlova, et al.
Published: (2022-12-01)

QUALITY MANAGEMENT SYSTEM IN A HEALTHCARE ORGANISATION: FROM BASICS TO OPERATING MODEL
by: I.V. VINOGRADOVA, et al.
Published: (2022-12-01)

Ritual complexes ("geoglifs") of the Turgay Deflection (preliminary message)
by: Logvin, A.V., et al.
Published: (2018-07-01)

Clinical features of pneumonia with adverse outcome (based on materials of the therapeutic department of the Angapov Republican Clinical Emergency Hospital, Ulan-Ude for 2013-2015)
by: E. V. Bashkueva, et al.
Published: (2017-09-01)

Vaccination with virus-like particles containing hemagglutinin protects the lungs of mice with postifluenza bacterial pneumonia: virological, microbiological and clinical data
by: I. N. Falynskova, et al.
Published: (2020-07-01)

An association between low vitamin D status and childhood pneumonia severity in hospitalized bulgarian patients
by: N. Rimpova, et al.
Published: (2022-05-01)

CONCEPT OF THE DEVELOPMENT OF DECISION SUPPORT IN EMERGENCY
by: O.V. OLKHOVIK, et al.
Published: (2010-06-01)

ASSOCIATION OF TLR2, TLR4, TLR9 GENE EXPRESSION RELATED TO INNATE IMMUNITY WITH IN VIVO ACUTE RESPIRATORY INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE
by: E. V. Budanova, et al.
Published: (2018-06-01)

Association of Baseline Levels of C-Reactive Protein and Neutrophil to Lymphocyte Ratio in Assessing Severity and Mortality among COVID-19 Patients in Three Waves: A Cross-sectional Study
by: Umalakshmi Annavarapu, et al.
Published: (2023-07-01)